Journal article 815 views 74 downloads
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
,
Megan Karwan,
Lilia Ileva ,
Michelle K. Ozaki,
Robert Y.S. Cheng ,
Lisa A. Ridnour,
Christina M. Annunziata ,
David A. Wink,
Daniel W. McVicar
Journal of Clinical Investigation, Volume: 128, Issue: 9, Pages: 3794 - 3805
Swansea University Author:
Luke Davies
-
PDF | Version of Record
This work is licensed under the Creative Commons Attribution 4.0 International License.
Download (2.73MB)
DOI (Published version): 10.1172/jci99169
Abstract
Control of cellular metabolism is critical for efficient cell function, although little is known about the interplay between cell subset–specific metabolites in situ, especially in the tumor setting. Here, we determined how a macrophage-specific (Mϕ-specific) metabolite, itaconic acid, can regulate...
| Published in: | Journal of Clinical Investigation |
|---|---|
| ISSN: | 0021-9738 1558-8238 |
| Published: |
American Society for Clinical Investigation
2018
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa61700 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
Control of cellular metabolism is critical for efficient cell function, although little is known about the interplay between cell subset–specific metabolites in situ, especially in the tumor setting. Here, we determined how a macrophage-specific (Mϕ-specific) metabolite, itaconic acid, can regulate tumor progression in the peritoneum. We show that peritoneal tumors (B16 melanoma or ID8 ovarian carcinoma) elicited a fatty acid oxidation–mediated increase in oxidative phosphorylation (OXPHOS) and glycolysis in peritoneal tissue–resident macrophages (pResMϕ). Unbiased metabolomics identified itaconic acid, the product of immune-responsive gene 1–mediated (Irg1-mediated) catabolism of mitochondrial cis-aconitate, among the most highly upregulated metabolites in pResMϕ of tumor-bearing mice. Administration of lentivirally encoded Irg1 shRNA significantly reduced peritoneal tumors. This resulted in reductions in OXPHOS and OXPHOS-driven production of ROS in pResMϕ and ROS-mediated MAPK activation in tumor cells. Our findings demonstrate that tumors profoundly alter pResMϕ metabolism, leading to the production of itaconic acid, which potentiates tumor growth. Monocytes isolated from ovarian carcinoma patients’ ascites fluid expressed significantly elevated levels of IRG1. Therefore, IRG1 in pResMϕ represents a potential therapeutic target for peritoneal tumors. |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
This
research was supported by the Intramural Research Program of
the NIH, NCI, CCR. LCD is funded by the Henry Wellcome Trust,
United Kingdom (WT103973MA) |
| Issue: |
9 |
| Start Page: |
3794 |
| End Page: |
3805 |